Safety first
Guide / Research briefs

National Skin Cancer Burden from Indoor Tanning: A Study Breakdown

Published October 28, 2026 · MTI Editorial Team · Sources linked on this page

!
Educational information only. Not medical advice and no dosing information. Melanotan I and II sold online are not FDA-approved. Talk to a licensed doctor.
Indoor Tanning and Skin Cancer Burden: The 2019 Canadian Study
Photo: "Tanning bed, May 2009 (brightened)" by TimOve, CC BY 2.0, via Wikimedia Commons (cropped).

Recreational tanning devices have long been examined for their biological and clinical impacts on human skin. While laboratory research illustrates how artificial ultraviolet radiation harms cellular structures, epidemiologists often seek to understand what proportion of real-world cancer diagnoses trace back to sunlamp exposure across an entire country. A key investigation addressing this population-scale question was published in Cancer epidemiology under the title Indoor tanning and skin cancer in Canada: A meta-analysis and attributable burden estimation. By applying established epidemiological modeling to national records, the authors aimed to calculate the specific share of malignancies tied directly to sunlamps.

Why evaluate tanning lamps through population attributable risk?

Clinical registries record how many individuals receive a cancer diagnosis, but overall case counts do not instantly reveal how many tumors were triggered by a specific preventable behavior. To bridge that gap, researchers use population attributable risk formulas. This statistical approach evaluates both how widespread an exposure is within the general populace and how much that exposure multiplies an individual's baseline probability of getting sick.

By determining the attributable fraction, public health specialists can estimate the burden that might theoretically be avoided if the exposure did not exist. For individuals researching skin safety, sunlamps, or products marketed for tanning such as unapproved melanotan peptides sold illicitly online, examining population-level research highlights the documented clinical realities of ultraviolet devices without relying on marketing claims.

How was this 2019 Canadian study designed?

To establish a rigorous national model, the study authors combined several datasets using Levin's population attributable risk formula:

  • Exposure prevalence: The team obtained data on how many people had ever used indoor tanning devices from the 2006 National Sun Survey.
  • Cancer incidence records: Age- and sex-specific figures for melanoma cases diagnosed in 2015 were drawn directly from the Canadian Cancer Registry.
  • Non-melanoma estimates: Incidence projections for keratinocyte carcinomas were gathered from the 2015 Canadian Cancer Statistics report.
  • Risk estimation: Meta-analyses were conducted to establish pooled relative risks for different malignant subtypes relevant to the Canadian population.

Synthesizing these sources allowed the investigators to project the distinct proportion of annual malignancies attributable to ever having used tanning equipment.

What relative risks and attributable fractions did the study report?

The meta-analytic portion of the 2019 study showed an elevated relative risk across all primary forms of skin malignancy among individuals who reported ever using indoor tanning devices. Specifically, the relative risk was calculated at:

  • Melanoma: 1.38
  • Basal cell carcinoma: 1.39
  • Squamous cell carcinoma: 1.49

When applying these relative risks alongside national exposure prevalence figures, the paper estimated that indoor tanning accounted for substantial portions of the total diagnoses recorded in Canada in 2015. Specifically, ever using tanning devices was responsible for 7.0% of melanomas, 5.2% of basal cell carcinomas, and 7.5% of squamous cell carcinomas. You can read more about how artificial radiation compares across malignancies in our guide on tanning beds and UV risk, as well as our review of the biological types of skin cancer.

How did the attributable burden vary by age and sex?

The investigation demonstrated clear demographic variations in who carried the highest burden of disease. According to the published results, population attributable risks were notably higher for women than for men. Furthermore, the attributable proportions decreased with advancing age.

These demographic patterns reflect differences in historical sunlamp usage captured in survey data, where younger cohorts and female participants historically reported greater participation in salon tanning. Because the attributable fraction depends directly on how many people in a given subgroup were exposed, higher usage rates among younger women translated into a larger fraction of their cancer diagnoses being linked directly to sunlamps.

What are the limitations and scope of this single study?

When interpreting these findings, it is essential to recognize the inherent design boundaries of observational modeling. First, this paper represents a single study focused on data from Canada, meaning its precise percentage findings reflect the specific indoor tanning habits and baseline demographics of that country.

Second, Levin's formula relies on mathematical assumptions, including the premise that the relative risks gathered from meta-analyses accurately apply across the modeled population. Third, the exposure prevalence was derived from a single historical instrument, the 2006 National Sun Survey, to evaluate diagnoses in 2015. While latency periods between ultraviolet exposure and tumor development necessitate looking back at past behavior, surveys always carry some degree of self-reporting bias.

Despite these limitations, the authors concluded that recreational sunlamps contribute a considerable burden of skin malignancy, prompting their recommendation that health regulators consider restrictions on device intensity or access bans. For personalized guidance regarding skin exams, mole changes, or ultraviolet history, individuals should always consult a board-certified dermatologist or primary care doctor.

Sources

Indoor tanning and skin cancer in Canada: A meta-analysis and attributable burden estimation. - Cancer epidemiology (PubMed PMID 30639817)

Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.